IBD and Antibiotic Use —A study out of Sweden presents evidence that cumulative exposure to antibiotics increases risk of new-onset IBD.

Q: How about biologics? Are there concerns with using them in IBD? Pyrsopoulos: Biologics are often used to treat moderate-to-severe disease states in IBD.

Certain diets can help improve inflammatory bowel disease (IBD) symptoms and support gut health—particularly those rich in ...

SAN DIEGO -- Biomarker-informed therapy guidance improved disease control rates among patients with inflammatory bowel disease (IBD) compared with standard best care, a randomized trial showed.

So, the concern is that using these immune-weakening therapies in patients with more advanced IBD caused by CGD could put these patients at an unacceptably high risk of infection.

Coelho-Prabhu added that current research assessing AI for IBD has focused on using images or video data to identify disease severity and grading as well as predict endoscopic and histologic healing.

The risk for inflammatory bowel disease is higher in patients with psoriasis or ankylosing spondylitis using IL-17A inhibitors than in those using apremilast, necessitating careful patient monitoring.

Alternative strategies to ease mood, anxiety, and sleep disorders are needed to curb high persistent use of benzodiazepines and Z-drugs in the IBD population, researchers say.